GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PD-RX Pharmaceuticals Inc (OTCPK:PDRX) » Definitions » YoY EBITDA Growth

PD-RX Pharmaceuticals (PD-RX Pharmaceuticals) YoY EBITDA Growth : 0.00% (As of . 20)


View and export this data going back to . Start your Free Trial

What is PD-RX Pharmaceuticals YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. PD-RX Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in . 20 was 0.00%.

PD-RX Pharmaceuticals's EBITDA per Share for the three months ended in . 20 was $0.00.

PD-RX Pharmaceuticals YoY EBITDA Growth Historical Data

The historical data trend for PD-RX Pharmaceuticals's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PD-RX Pharmaceuticals YoY EBITDA Growth Chart

PD-RX Pharmaceuticals Annual Data
Trend
YoY EBITDA Growth

PD-RX Pharmaceuticals Quarterly Data
YoY EBITDA Growth

PD-RX Pharmaceuticals YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

PD-RX Pharmaceuticals's YoY EBITDA Growth for the fiscal year that ended in . 20 is calculated as:

YoY EBITDA Growth (A: . 20 )
=(EBITDA per Share (A: . 20 )-EBITDA per Share (A: . 20 ))/ | EBITDA per Share (A: . 20 ) |
=(-)/ | |
=N/A %

PD-RX Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in . 20 is calculated as:

YoY EBITDA Growth (Q: . 20 )
=(EBITDA per Share (Q: . 20 )-EBITDA per Share (Q: . 20 )) / | EBITDA per Share (Q: . 20 )) |
=(-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PD-RX Pharmaceuticals YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of PD-RX Pharmaceuticals's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

PD-RX Pharmaceuticals (PD-RX Pharmaceuticals) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PD-RX Pharmaceuticals Inc (OTCPK:PDRX) » Definitions » YoY EBITDA Growth
Comparable Companies
BOM:536565 TSXV:MNX BOM:530697 STU:BMP HKSE:00401 HKSE:08372 SNYR ISX:SDPC BOM:540695 FZMD XMAD:MED HKSE:00858 TSXV:KDA BKK:TM ROCO:6637 TSE:9265 BKK:EFORL TSE:7681 TSE:2689 XLJU:SALR
Traded in Other Exchanges
N/A
Address
727 North Ann Arbor Avenue, Oklahoma City, OK, USA, 73127-5822
Website
https://www.pdrx.com
PD-RX Pharmaceuticals Inc provides and distributes a complete line of brand and generic pharmaceuticals, unit dose products, unit of use, injectables, creams, ointments, and medical and surgical supplies.

PD-RX Pharmaceuticals (PD-RX Pharmaceuticals) Headlines

From GuruFocus

PD-Rx Declares Dividend

By PRNewswire PRNewswire • 05-07-2018

PD-Rx Declares Dividend

By PRNewswire PRNewswire • 12-06-2018